(SeaPRwire) – By: Fiona MacIntyre
The market is treating IonQ like a pure-play quantum darling. That is a misread. After the $1.8 billion SkyWater Technology acquisition closed in late July, IonQ stopped being just a quantum computing firm. It is now a semiconductor fabrication house with a quantum research division attached. The September 8 investor day will force everyone to reconcile with that reality. Analysts like StoneX’s Gary Mobley are already doing the math, and the numbers get ugly before they get pretty.
Let’s strip the PR layer off the Q2 earnings. Revenue hit $80.05 million, up 287% year over year, beating a $66.47 million consensus. The adjusted loss per share of $0.33 also beat expectations. Good headlines. But the quarter closed before the SkyWater deal fully landed. The acquisition closed in late July, meaning Q2 numbers reflect almost none of the foundry’s operational drag or its internal revenue cancellation. Mobley flags that IonQ was on track to pay SkyWater $120 million in 2026, with $80 million coming in the second half. That is not revenue. That is an internal transaction that evaporates post-acquisition. Analysts need to shave SkyWater’s top-line contribution by roughly 20% just to get a clean number. The deal will also compress margins and absorb around $93 million in operating expenses this year.
The strategic logic for the acquisition is real, even if the accounting is messy. Control of the foundry lets IonQ pull its 200,000 qubit roadmap forward by roughly a year, aligning with the executive order demanding a fault-tolerant quantum computer at a national lab by 2028. Vertically integrating fabrication gives them a chip design and advanced packaging business they can sell to third parties. That is a revenue stream outside quantum entirely. It is also a physical hedge against supply chain constraints that have strangled smaller quantum players. The question is whether the Street is pricing the hedge correctly.
The honest read is that IonQ is betting on a specific timeline for fault-tolerance. The 2028 national lab order is the forcing function. Management’s job at the investor day is to convince investors that SkyWater’s silicon lines can produce enough margin and yield to fund the quantum roadmap without endless dilution. That is a hard sell when the warrants expire September 30. If exercised, they flood the share count and add near-term pressure. The stock opened at $37.87 against a $69.92 consensus target, and with nine Buys, four Holds, and one Sell, the analyst community is far from unified.
The technical credibility is improving. The drug discovery demonstration with QC Ware, running a hybrid quantum-classical chemistry workflow on the Forte system via Amazon Braket, hit results within 4% of a benchmark. That clears the chemical-accuracy bar cited for pharmaceutical research. It gives IonQ a second narrative beyond qubit counts, which matters because qubit count alone no longer impresses anyone who has watched quantum hype cycles burn out. Practical workloads in chemistry are worth real contract dollars.
CEO Niccolo de Masi wants to be the Nvidia of quantum. That is the right ambition and the wrong comparison. Nvidia’s moat is CUDA’s software lock-in. IonQ’s emerging moat is a captive fab and a physical supply chain. If the September 8 guidance shows SkyWater can generate external foundry revenue to subsize the quantum division, the stock deserves a fresh look. If the guidance leans on back-end loaded qubit milestones, the dilution risk will cap the upside.
Author bio: Fiona MacIntyre, independent physics researcher and consultant advising emerging compute hardware clusters on fabrication roadmaps and quantum technology commercialization timelines.